Aims Over the past 25 years there has been a substantial development in the field of digital
electrophysiology (EP) and in parallel a substantial increase in publications on digital …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Cardiovascular disease is the primary cause of morbidity and mortality worldwide.
Cardiologists face challenges in clinical decision-making because of the demands for better …

The 2020 ESC atrial fibrillation (AF) guidelines suggest the novel 4S-AF scheme for the
characterization of AF. Imaging techniques could be helpful for this objective in everyday …

Late recurrence of atrial fibrillation (LRAF) in the first year following catheter ablation is a
common and significant clinical problem. Our study aimed to create a machine-learning …

Atrial fibrillation (AF) affects more than 30 million individuals worldwide, making it the most
prevalent cardiac arrhythmia on a global scale. This systematic review summarizes recent …

There has been a significant increase in the prevalence of atrial fibrillation (AF) over the past
30 years. 3 Pulmonary vein isolation (PVI) is an effective treatment for atrial fibrillation (AF) …

The relationship between epicardial adipose tissue (EAT) and atrial fibrillation (AF) has
gained interest in recent years. The previous literature on the topic presents great …

Abstract Polygenetic Risk Scores are used to evaluate an individual's vulnerability to
developing specific diseases or conditions based on their genetic composition, by taking …

Aims Epicardial adipose tissue might promote atrial fibrillation (AF) in several ways,
including infiltrating the underlying atrial myocardium. However, the role of this potential …